Oral Contraceptives in Women With Diabetes

Barbara EK Klein; Scot E Moss; Ronald Klein

doi:10.2337/diacare.13.8.895

Short Reports

Oral Contraceptives in Women With Diabetes

Barbara EK Klein, MD, MPH,
Scot E Moss, MA and
Ronald Klein, MD, MPH

Department of Ophthalmology, University of Wisconsin Medical School Madison, Wisconsin

Address correspondence and reprint requests to Barbara E.K. Klein, MD, Department of Ophthalmology, Clinical Science Center, 600 Highland Avenue, Madison, WI 53792.

Diabetes Care 1990 Aug; 13(8): 895-897. https://doi.org/10.2337/diacare.13.8.895

Abstract

We evaluated the association of oral contraceptive use with the presence and severity of diabetic retinopathy, hypertension, and glycosylated hemoglobin in women of childbearing age who have diabetes. Neither current or past use nor number of years of use of oral contraceptives was associated with severity of retinopathy, hypertension, or current glycosylated hemoglobin. In conclusion, further study of various birth control methods in young women of childbearing age should be considered.